{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Passage Bio, Inc."},"Symbol":{"label":"Symbol","value":"PASG"},"Address":{"label":"Address","value":"2005 MARKET STREET,39TH FLOOR, ONE COMMERCE SQUARE, PHILADELPHIA, Pennsylvania, 19103, United States"},"Phone":{"label":"Phone","value":"+1 267 866-0311"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.passagebio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alex Fotopoulos","title":"Chief Technical Officer"},{"name":"Andrea Campanile","title":"Vice President-Clinical Operations"},{"name":"Eden Fucci","title":"Senior Vice President-Technical Operations"},{"name":"Susan Browne","title":"Chief Scientific Officer"},{"name":"William Chou","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}